(Q45246975)

11 December 2017

title

Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder (English)

1 reference

Invasive urothelial carcinoma

11 December 2017

main subject

1 reference

5

1 reference

11 December 2017

Hang Wang

1

1 reference

11 December 2017

Roula Albadine

2

1 reference

11 December 2017

Ahmed Magheli

3

1 reference

11 December 2017

Thomas J Guzzo

4

1 reference

11 December 2017

Stefan Hinz

6

1 reference

11 December 2017

Mark P Schoenberg

7

1 reference

11 December 2017

George J Netto

8

1 reference

11 December 2017

Mark L Gonzalgo

9

1 reference

11 December 2017

publication date

10 March 2011

1 reference

11 December 2017

1 reference

11 December 2017

volume

30

1 reference

11 December 2017

issue

4

1 reference

11 December 2017

page(s)

428-433

1 reference

Bladder cancer: epidemiology, staging and grading, and diagnosis.

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.09.005

Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.09.005

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.09.005

SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.09.005

Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.09.005

The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.09.005

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.09.005

EZH2 promotes proliferation and invasiveness of prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.09.005

Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.09.005

The polycomb group protein EZH2 is involved in progression of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.09.005

EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.09.005

Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.09.005

Increased expression of EZH2, a polycomb group protein, in bladder carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.09.005

Expression of the polycomb group protein EZH2 and its relation to outcome in patients with urothelial carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.09.005

Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.09.005

Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.09.005

Diagnostic tests 3: receiver operating characteristic plots

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.09.005

10.1016/J.UROLONC.2010.09.005

7 January 2021

Identifiers

DOI

1 reference

11 December 2017

1 reference